Financials
- Market Capitalization 2.32 B
- Employee 357
- Founded 2009
- CEO N/A
- Website www.nurixtx.com
- Headquarter Delaware, United States
- FIGI BBG00SDJ8M78
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-5.54
Relación precio/flujo de caja
17.45
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1847 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 4.36 USD | +10.38% | +4.31% | +36.25% | -20.73% | 2.33 B USD | ||
| 1850 | ADMA ADMA Biologics Inc - Common Stock | 10.36 USD | +0.29% | +7.58% | +11.04% | -28.85% | 2.32 B USD | ||
| 1884 | IMNM Immunome, Inc. - Common Stock | 19.55 USD | +1.24% | -5.96% | -20.20% | +40.45% | 2.22 B USD | ||
| 1887 | AUPH Aurinia Pharmaceuticals Inc - Common Shares | 16.65 USD | +2.65% | +5.65% | +3.16% | +39.56% | 2.22 B USD |